Biphasic transition curve on denaturation of chicken cystatin by guanidinium chloride Evidence for an independently unfolding structural region  by Björk, Ingemar & Pol, Ewa
Volume 299, number 1, 66--68 FEBS 10787 
© 1992 Federation of European Bioeliemieal Societies 00145793/92/$5.00 
March 1992 
Biphasic transition curve on denaturation of chicken cystatin by 
guanidinium chloride 
Evidence for an independently unfolding structural region 
I ngemar  BjOrk and Ewa Pol  
Department of Veterinary Medical Citemlstry, Swedish University of Agricultural Sciences, Uppsala Biomedical Center, Box $75, 
$.7M 23 Uppsala, Sweden 
Received 23 December 1991; revised version received 17 January 1992 
FaPultrav~let circular diohroism and tryptophan fluorescence measurements showed that the reversible unfolding of the c3,steine proteinase 
inhibitor, chicken eystatin, by guanidinium chloride is a two-step rocess with transition midpoints at ..-3.4 and ~5.4 M denaturant. The partially 
unfolded intermediate had both far- and near-ultraviolet circular diehroism and fluorescence emission spectra comparable tothose of the native 
protein. The largely retained tertiary structure suggests hat he intermediate represents a pecies inwhich a separate r gion of lower stability has 
been unfolded, rather than an intermediate of the 'molten globule' type. Such a structurally independent region is apparent inthe three-dimensional 
structure of the inhibitor. 
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I. INTRODUCTION 
Chicken cystatin isolated from egg white is the best 
characterized member of  the family II cystatins, which 
are extracellular cysteine proteinase inhibitors of  ",-120 
amino acid residues with two disulfide bridges [1]. A 
homologous inhibitor, cystatin C, is the predominant 
member of this family in humans and presumably also 
other mammals [2], Chicken cystatin and human cy- 
statin C inactivate mammalian cysteine proteinases, e.g. 
cathepsins B, H and L, and also several structurally 
related plant enzymes, such as papain and actinidin, by 
forming tight (K a = 5 nM-60 fM), equimolar complexes 
with the enzymes [1-51. The crystal structure of  chicken 
cystatin [6,7] suggests that the proteinase binding site 
comprises three regions of  the polypeptide chain, which 
together form a wedge-shaped ge of the molecule that 
fits into the active-site cleft of papain with minimal 
conformational changes of either protein. The spectro- 
scopic and kinetic characteristics of the interactions of  
chicken cystatin and cystatin C with those target 
proteinases that have been studied so far are highly 
similar [2,5,8], indicating that the two inhibitors bind to 
the enzymes in a closely related manner. 
In this work we show that the reversible unfolding of 
chicken cystatin by guanidinium chloride is a two-step 
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process. The stable intermediate on the unfolding 
pathway retains a considerable amount of  the second- 
ary and tertiary structure of  the native protein and thus 
most likely represents a species in which a separate 
structural region of lower stability has been unfolded, 
These results, which can be interpreted in terms of tim 
known X-ray structure of chicken cystatin [6,7], pre- 
sumably can be extended also to human cystatin C be- 
cause of the high similarity between the two proteins. 
2. MATERIALS AND METHODS 
Chicken ¢ystatin (form 1) and papain (EC 3.a.22,2) wore purified 
and their concentrations determined asdescribed earlier [3]. Gnani- 
dinium chloride ('ARIgTAR' quality) was obtained from BDH Ltd,, 
Peele, England. Concentrations f the denaturant were determined by
densitometry [9], 
Circular dichroism was measured at25:1: 0,1*C with a Jasco J-41A 
Sl~ctro-polarimeter (Japan Spectroscopic Co., Tokyo, Japan). 
Measurements in the far-ultraviolet wavelength region were done in 
ceils with 0.05- or 0.I-era path.lengths and with eystatin concentra- 
tions of 0.25-0.5 gel, whereas cells with 1 ¢m path-lengths and eystatin 
concentrations of 1.2 g/I wece used in the near-ultraviolet r gion. The 
bandwidth was 2 tam in both regions. 
Fluorescence measurements were done at 25 _ 0.1*C with an SLM 
48005 speetroflunrimeter (SLM.Amineo, Urbana, IL) in the ratio 
mode. The excitation and emission wavelengtM were 295 and 3S0 nm, 
with corresponding bandwidths of4 and 8 nm, respectively. Cells with 
excitation and emission path-lengths of 0.4 and 1 era, reepeetively, 
wer~ used, and the eystatin concentration was 0.25 g/l. Emission 
spectra were corrected for the wavelength-dependence of the in- 
strumental response. 
Titrations of papain, at a concentration f I/zM, with renatured 
eystatin for the determination of the binding stoiehiometry were men- 
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itorcd by the decrease of fluorescence emission intensity accompany. 
ing the interaction, as described previously [3]. 
Polyacrylamide gel eleetrophoresis under non.denaturing condi. 
tions was don¢ on 7% gels [I0]. 
3. RESULTS 
The unfolding of chicken cystatin in guanidinium 
chloride clearly is a two-step process with transition 
midpoints at ~3.4 and -5.4 M, as shown by both far- 
ultraviolet circular dichroism and tryptophan fluores- 
cence (Fig. 1). No further spectroscopic changes were 
observed after 24 h, when the result,= presented were 
obtained, indicating that equilibrium was attained 
within this time. 
Far and near-ultraviolet circular dichroism spectra of 
cystatin at 6.5 M guanidinium chloride (Fig. 2) were 
those of a typical polypeptide chain in random con- 
formation [11,12], indicating that the inhibitor is fully 
unfolded to a state approximating a disulphide-bonded 
random coil at this denaturant concentration. In con- 
trast, the spectra of cystatin in the partially unfolded 
state, existing around 4 M guanidinium chloride, were 
comparable with those of the native protein, suggesting 
that the protein in this state retains a considerable 
amount of secondary and tertiary structure (Fig. 2). 
Corrected fluorescence emission spectra (not presented) 
were consistent with the latter conclusion, showing a 
shift of the wavelength of the emission maximum from 
that of the native protein (347 nm) of -< 1 nm at 4.2 M 
guanidinium chloride, compared with a red shift of ~5 
nm for the fully unfolded protein at 6.5 M denaturant. 
The two-step unfolding process was fully reversible, 
as shown by circular dichroism and fluorescence 
measurements (Fig. 1). Moreover, cystatin renatured 
from 6.5 M guanidinium chloride by dialysis for -20 h 
against 0.05 M TRIS/HCI/0.1 M NaCI/100 ~M EDTA, 
pH 7.4, migrated like native cystatin in polyacrylamid¢ 
gel electrophoresis under non-denaturing conditions, 
with no evidence of aggregation. The renatured inhibi- 
tor bound to papain with a stoichiometry of inhibitor 
to enzyme of 1.1:1 and with a similar fluorescence de- 
crease as that accompany,ng the interaction between 
papain and native cystatin [3], showing that also the 
protcinase-binding activity of the inhibitor was 
regained. 
4. DISCUSSION 
The biphasic equilibrium denaturation curve of 
chicken cystatin in guanidinium chloride indicates that 
a stable, partially unfolded intermediate exists on the 
unfolding pathway. This intermediate has certain char- 
acteristics of the 'collapsed form' or 'moiten globule' 
demonstrated forthe unfolding of certain small proteins 
[13-16]. It thus has a high degree of secondary structure, 
as evident from its far-ultraviolet circular dichroism 
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Fig. 1. Unfolding of chicken cystatin at different concentrations of 
guanidinium chloride and refolding of the denatured protein from 6.5 
M $uanidinium chloride, as monitored by (A) far-ultraviolet circular 
dicbroism and (B) tryptophan fluorescence. Unfolding: buffer was 
mixed with cystatin (6-8.3 g/i) and guanidinium chloride (7.3-7.8 M) 
to tire appropriate concentration of denaturant and a final protein 
concentration of 0.25 $/1. Measurements were made after ~24 h at 
25°C by circular dichroism at wavelengths of225 (o), 220 (n) and 212 
(&) nm, and by fluorescence atexcitation and emission wavelengths 
of 295 and 350 nm, respectively (V). aefolding: cystatin, at a con- 
centration of 1.0 g/l, was kept in 6.5 M guanidinium chloride for 5-10 
rain, at which time unfolding was complete, as shown by no further 
spectroscopic changes occurring. The solution was then diluted with 
buffer and 6.5 M guanidinium chlorid~ to the appropriate concentra. 
tion of denaturant and a final protein concentration of 0.25 $/i. 
Measurements were made after ~24 h at 25°C by circular dichroism 
at wavelengths of 225 (e), 220 (B) and 2 i 2 (A) nm, and by f laor~nce  
as described ~bov¢ {I'.). All solutions in both the unfolding and refold- 
ing experiments contained 0.05 M TRIS/HCl/0.1 M NaCl, pH 7.4, as 
buffer. The circular diehroism results are given as mean residue d-  
iipticity, based on a mean re~idu, weight for cystatin of 113 [19]. The 
fluorescence r sults are expressed as the ratio between the fluorescence 
emission of the sample in the pmscnec of guanidinium chloride (F) to 
that in the absence of the denaturant (Fo). 
spectrum, and presumably is compact, as suggested by 
the fact that it was not detected by a gel chromato- 
graphic technique in previous unfolding studies of 
chicken cystatin [17]. However, the near.ultraviolet cir- 
cular dichroism and fluorescence emission spectra of 
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Fig. 2. Far-ultraviolet (A) and near-ultraviolet (B) circular dichroism 
spectra of chicken cystatin at different concentrations of gaanidinium 
chloride. The guanidinium chloride concentrations were 0 (--), 4.0 
( ...... ), 4,6 (-.-) and 6,5 (-,-.-,) M, Samples were prepared as described 
for the unfolding experiments in the legend to Fig, 1, except hat the 
protein concentration i the measurements of the near-ultraviolet 
spectra was 1.2 g/l. Far-ultraviolet six=otto f r cystatin in gaanidinium 
chloride could only be measured own to -208 rim, due to the high 
absorbanc¢ of the solvent. The unit on the ordinate is mean residue 
ellipticity (see the legend to Fig, 1) in (A) and molar ellipticity in (B). 
the intermediate are comparable with those of the native 
protein, a property not typical of the 'molten globule' 
state. Instead, this state is characterized by such spectra 
being similar to those of the fully unfolded protein, a 
finding that has been suggested toarise from a fluctuat- 
ing tertiary structure. 
A more plausible xplanation for the nature of the 
stable intermediate of chicken cystatin is that it re- 
presents a form in which a distinct structural region of 
the protein with lower stability has been unfolded [18]. 
Although chicken cystatin is a small protein, such a 
region is nevertheless apparent in the three-dimensional 
structure of the inhibitor. The polypP.ptide chain be- 
tween Pro-72 and Met-89 thus forms a slightly flexible 
tight turn, a 2.5-turn helical portion and a completely 
disordered four-residue segment, which together con- 
stitute a reasonably independent s ructural unit 1"6,7]. 
This region has substantial flexibility and, although dis- 
ulphide-bonded to the main fl-sheet of the protein, pre- 
sumably has a lower stability than the remainder of the 
protein. We propose that the partially unfolded inter- 
mediate represents a form in which this region has been 
unfolded. Such a form should be compact and retain a 
considerable amount of the secondary and tertiary 
~tructure of the native protein and thus have the 
properties of the observed intermediate. A correspond- 
ing structurally independent region most likely also ex- 
ists in human cystatin C because of the large structural 
and functional similarities between the two inhibitors. 
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